Bank of America Corp. Reiterates “Underperform” Rating for Cochlear (COH)
Cochlear (ASX:COH)‘s stock had its “underperform” rating reaffirmed by Bank of America Corp. in a research note issued on Tuesday, Stock Ratings Network reports.
A number of other analysts have also recently weighed in on COH. Analysts at Credit Suisse reiterated an “underperform” rating on shares of Cochlear (ASX:COH) in a research note to investors on Thursday, September 26th. Four analysts have rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of A$70.54 ($65.93).
Shares of Cochlear (ASX:COH) traded up 0.05% on Tuesday, hitting A$59.870. The stock had a trading volume of 80,621 shares. Cochlear has a one year low of A$52.710 and a one year high of A$82.870. The stock has a 50-day moving average of A$58.95 and a 200-day moving average of A$62.2. The company has a market cap of A$3.408 billion and a P/E ratio of 25.75.
Cochlear Limited (ASX:COH) is an Australia-based company, which operates in the implantable hearing device industry.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.